• Home
• Responsibility
• Research practices
• Clinical research
• Clinical trials in the developing world

Corporate Responsibility Report 2008

Clinical trials in the developing world

All GSK clinical trials, wherever they are carried out, are conducted to the same high standard.

GSK does not conduct clinical trials in countries when we know at the outset that there is no intent to pursue registration and make the product available for use in that country.

Additional steps may be needed to ensure that trials in some of the least developed countries are conducted according to the Good Clinical Practice (GCP) guidelines. For example, matching the objectives of informed consent to local culture may be necessary, for instance by involving local leaders and/or family members.

In some circumstances capacity may be provided to help develop a certain skill or competence, or for general upgrading of performance ability, which will facilitate the prospective conduct of clinical research activity not only for GSK but also the broader community.

Read more about post-trial treatment.

Read our position statement on clinical trials in the developing world.